These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33919415)

  • 1. Lyophilized Maqui (
    Sandoval V; Sanz-Lamora H; Marrero PF; Relat J; Haro D
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33919415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyophilized Maqui (
    Sandoval V; Femenias A; Martínez-Garza Ú; Sanz-Lamora H; Castagnini JM; Quifer-Rada P; Lamuela-Raventós RM; Marrero PF; Haro D; Relat J
    Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31480627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Rojo LE; Ribnicky D; Logendra S; Poulev A; Rojas-Silva P; Kuhn P; Dorn R; Grace MH; Lila MA; Raskin I
    Food Chem; 2012 Mar; 131(2):387-396. PubMed ID: 26279603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
    Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
    Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
    Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico and In Vivo Evaluation of the Maqui Berry (
    Castillo-García EL; Cossio-Ramírez AL; Córdoba-Méndez ÓA; Loza-Mejía MA; Salazar JR; Chávez-Gutiérrez E; Bautista-Poblet G; Castillo-Mendieta NT; Moreno DA; García-Viguera C; Pinto-Almazán R; Almanza-Pérez JC; Gallardo JM; Guerra-Araiza C
    Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hepatic steatosis by dietary fatty acids.
    Ferramosca A; Zara V
    World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Functional Characteristics and Applications of
    García-Milla P; Peñalver R; Nieto G
    Foods; 2024 Mar; 13(6):. PubMed ID: 38540828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
    Eissing L; Scherer T; Tödter K; Knippschild U; Greve JW; Buurman WA; Pinnschmidt HO; Rensen SS; Wolf AM; Bartelt A; Heeren J; Buettner C; Scheja L
    Nat Commun; 2013; 4():1528. PubMed ID: 23443556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.